A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
Clinical trial NCT06947941 · RECRUITING
Trial details
- NCT number
- NCT06947941
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-25
- Primary completion
- 2028-02-21
- Enrollment
- 325
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.